Inhalation Anesthesia Market Report 2026

Inhalation Anesthesia Market Overview

• Inhalation Anesthesia market size has reached to $1.64 billion in 2025 • Expected to grow to $2.51 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Rising Geriatric Population Driving Growth In The Inhalation Anesthesia Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Inhalation Anesthesia Market?

Inhalation anesthesia refers to medications used in operating rooms to induce and maintain general anesthesia. In addition to other therapeutic effects, it causes drowsiness that ranges from mild to severe, up to and including general anesthesia. Inhalation anesthesia is used for the induction and maintenance of general anesthesia in the operating room. The main product of inhalation anesthesia includes sevoflurane, desflurane, isoflurane, and nitrous oxide. Isoflurane is a general anesthetic that is inhaled and used to induce and maintain general anesthesia. It relaxes muscles and reduces pain sensitivity by modifying tissue excitability. The applications of inhalation anesthesia include induction and maintenance. The end-users of inhalation anesthesia include hospitals and ambulatory surgical centers.

What Is The Inhalation Anesthesia Market Growth Forecast?

The inhalation anesthesia market size is expected to see strong growth in the next few years. It will grow to $2.51 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to adoption of AI-assisted anesthesia, demand for sustainable anesthetic agents, integration of IoT in operating rooms, growth in outpatient surgeries, development of smart anesthesia delivery systems. Major trends in the forecast period include enhanced patient safety protocols, advanced anesthesia delivery systems, minimally invasive surgery support, real-time anesthesia monitoring, environmentally friendly anesthetic agents.

Global Inhalation Anesthesia Market Segmentation

1) By Product: Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide 2) By Application: Induction, Maintenance 3) By End User: Hospitals, Ambulatory Surgical Centers

What Are The Drivers Of The Inhalation Anesthesia Market?

The increasing geriatric population is anticipated to propel the growth of inhalation anesthesia during the forecast period. The increasing geriatric population is boosting the inhalation anesthesia market, as they are highly prone to degenerative diseases and chronic illnesses, which eventually leads to a rise in surgeries and therapeutics. Moreover, the increasing geriatric population, which is more susceptible to ailments, such as cardiovascular, neurological, respiratory, and degenerative disorders, is boosting the market growth. It is usually inconvenient to administer anesthesia through an intravenous route to geriatric patients due to punctured blood vessels and issues with patient compliance. For instance, in July 2024, according to the UK Parliament's House of Commons Library, a UK-based government administration, in 2022, there were 12.7 million people aged 65 or older in the UK. This number is projected to rise to 22.1 million by 2072, accounting for 27% of the population. Therefore, the increasing geriatric population is expected to boost demand for inhalation anesthesia during the forecast period. The rise in chronic diseases is expected to propel the growth of the inhalation anesthesia market going forward. Chronic diseases are long-term medical conditions that persist over an extended period, typically three months or more. Inhalation anesthesia is a crucial component of healthcare, as it is essential for ensuring the comfort and safety of patients during surgical interventions that are often necessary for the diagnosis, treatment, or management of many chronic diseases. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the rise in chronic diseases will drive the growth of the inhalation anesthesia industry.

Key Players In The Global Inhalation Anesthesia Market

Major companies operating in the inhalation anesthesia market are AbbVie Inc., Baxter International Inc., Sandoz AG, Piramal Enterprises Limited, Fresenius SE & Co KGaA, Hikma Pharmaceuticals PLC, Jiangsu Hengrui Medicine Co Ltd, Lunan Pharmaceutical Group Co Ltd, Troikaa Pharmaceuticals Ltd, Dechra Pharmaceuticals PLC, Aspen Pharmacare Holdings Limited, Maruishi Pharmaceutical Co Ltd, Nikko Chemicals (Japan), GlaxoSmithKline PLC, Boehringer Ingelheim International GmbH, Halocarbon Products Corporation, Abbott Laboratories, Baxter Healthcare (distinct manufacturing division) , Fresenius Kabi AG, Sedana Medical AB

What Are Latest Mergers And Acquisitions In The Inhalation Anesthesia Market?

In November 2024, Sedana Medical AB, a Sweden-based provider of inhaled-sedation and inhalation-anesthesia products, acquired Innovatif Cekal Sdn Bhd for USD 3.6 million (34 million SEK). Through this acquisition, Sedana Medical aims to enhance supply-chain control, lower production costs, and secure long-term manufacturing capacity for its inhaled-anesthesia devices by integrating the production of the Sedaconda ACD and related accessories. Innovatif Cekal Sdn Bhd is a Malaysia-based provider of device components and contract manufacturing services for the Sedaconda ACD, a key device used to administer volatile inhalation anesthetics to mechanically ventilated patients.

Regional Insights

North America was the largest region in the inhalation anesthesia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Inhalation Anesthesia Market?

The inhalation anesthesia market consists of sales of nitrous oxide, halothane, isoflurane, desflurane, and sevoflurane. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Inhalation Anesthesia Market Report 2026?

The inhalation anesthesia market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the inhalation anesthesia industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.